Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,902 total articles
Lumine Group (LMGIF) trades near its 52-week low after a sharp derating. The announced Synchronoss acquisition should be accretive to scale and recurring revenue; combined with a crowded short interest profile that is moderating and bullish technical signals, this creates a risk-reward favorable for a contrarian buy at current levels.
Nucor (NUE) is an investable way to play a steel reflation with downside protection. The stock sits near $175 after tariff-driven swings; fundamentals point to resiliency: $40.1B market cap, EPS of $7.20, P/E ~24.9, debt/equity 0.33. Trade plan: enter $175.19, stop $165.00, target $197.00 over a medium-to-long holding period while monitoring tariff…
PayPal spiked on buyout whispers, but the company’s real problems — slowing growth, leadership turnover and pending litigation — make a strategic buyout unlikely and the rally unsustainable. This trade idea proposes a mid-term short to capture mean reversion as the market re-prices execution risk away from takeover speculation.
Bumble ($BMBL) trades at distressed multiples after a multi-quarter user slump and litigation overhang. With reports that the TRA-related settlement has removed a meaningful headline risk and a relatively healthy free cash flow base ($173.8M), the upcoming earnings release is a catalyst that could re-rate the stock. Entry at $2.92, stop $2.60, targ…
Netflix looks set for another material re-acceleration driven by ad-tier monetization, international price normalization and a stronger content cadence. I’m upgrading the rating to Buy and laying out an entry at $450, a $650 target and a $395 stop-loss for a long-term trade (180 trading days).
Sandisk (SNDK) looks set to benefit from a NAND supply squeeze driven by hyperscaler AI buildouts. The stock has already rallied hard, but fundamentals - positive free cash flow, low leverage, and strong demand for SSDs - argue for additional upside. This trade idea lays out a long entry, disciplined stop and target for a long-term position trade o…
Novo Nordisk plunged after its REDEFINE 4 trial fell short versus tirzepatide, but the company's core GLP-1 franchise, cash flow profile and a 3.1% yield make a defined-risk swing long attractive. Entry $38.60, stop $35.00, target $53.04 (swing, 45 trading days).
BorgWarner remains a competitor with the product set automakers need for mixed ICE, hybrid and EV powertrains, but recent multiple expansion and cyclical demand make upside limited from current levels. Valuation (market cap ~ $12.2B, P/E ~45x) leaves little room for execution misses. We favor a tactical short over the next 45 trading days with clea…
Carnival (CCL) is riding strong booking trends and visible margin improvement driven by debt reduction and lower interest costs. At $31.54 the stock trades at mid-teens P/E with EV/EBITDA below 10 and free cash flow of roughly $2.6B — a setup where operational leverage and cash-flow conversion can drive a 15-25% move higher if bookings and onboard …
Kingstone Companies (KINS) is a small Northeast P&C insurer trading at a single-digit P/E with 29% reported ROE, low leverage and strong free cash flow. We think the shares can rally to the mid-$20s as underwriting performance stabilizes and the market re-rates a high-ROE, capital-efficient insurer. Trade plan, catalysts and risks below.
Emeren Group Ltd (SOL) is a sub-$100M market-cap renewable developer with electricity generation as its core revenue. Technicals show bullish momentum and the company operates across China and several European markets. This trade idea treats SOL as a speculative, event-driven long: buy at $1.86, stop at $1.40, target $2.40 over a mid-term horizon o…
MoonLake is a speculative buy on a high-impact regulatory binary: sonelokimab still appears to have a credible pathway to a Biologics License Application (BLA) win. With limited publicly circulated financials available in recent feeds, this trade treats the stock as a clinical-stage biotech binary with asymmetric upside if the BLA clears and define…
Tarsus (TARS) stock has re-rated on early commercial traction for XDEMVY and a positive technical backdrop. The company’s market cap sits around $3.2B with a tight float and elevated short interest — a setup that can amplify moves. This trade idea proposes a long entry near $75.61 with a $115 target over a 180 trading-day horizon and a stop at $60 …
<p>Nintendo's pullback has created a tactical buying opportunity. With market cap near $71.2B, a modest dividend yield and strong Switch 2 unit momentum, the company looks better positioned to benefit from high-quality IP and distribution control than to be disrupted by early-stage AI game builders. Technicals show oversold conditions but improving…
Kratos (KTOS) is uniquely positioned at the intersection of drones, hypersonics and affordable mission systems. Recent contract wins, inclusion in multi-billion defense programs and a strong liquidity position make KTOS a high-conviction tactical long for investors willing to accept above-average valuation for outsized program upside. Trade plan be…
Blue Owl Technology Finance (OTF) currently trades at a steep valuation discount to book and delivers a near-9.4% yield while showing recent portfolio momentum. The market is under-pricing the business risk relative to the income and upside from a re-rating. This trade idea lays out an actionable long with an entry at $11.37, stop at $10.50 and tar…
AMD jumped after Meta committed to a multi-year supply of AMD Instinct GPUs and received warrants that make Meta a potential major stakeholder. The headline is real revenue visibility for data center GPUs; the trade here is to capture the post-news momentum into a reasonable target while protecting against dilution, competitor wins, and AI-cycle ro…
Palo Alto Networks (PANW) pulled back after a Q3 earnings cycle that mixed slower organic growth guidance with an EPS miss driven by share dilution. Fundamentals still show strong cash generation and secular tailwinds in endpoint and malware detection markets. Technicals are deeply oversold and valuation has compressed after the drop — this trade t…
Avantor's recent pullback centers on a large goodwill impairment, softer biopharma demand and litigation headlines. The market cap now sits near $6.1B while free cash flow remains roughly $495M, implying a double-digit FCF yield and a valuation that looks forgiving for a company with a working balance sheet and buyback authorization. This trade ide…
Lululemon checks a lot of boxes for a mid-term long trade: strong free cash flow ($1.13B), a conservative EV/EBITDA (~6.8x), healthy margins and liquidity, and technical momentum. A recent tariffs ruling appears to ease a key headwind that has weighed on margins and sentiment. Enter near $180 with a $195 target and a $168 stop for a mid-term trade …
Coeur Mining (CDE) is trading at $24.37 with a market cap around $15.6B despite a recently reported 4.4M oz of proven and probable gold reserves valued at roughly $22.1B at current gold. The balance sheet is clean, free cash flow is robust ($665.7M last reported), and technicals show short-term momentum. This trade idea buys that gap between reserv…
Hubbell combines stable electrical-products cash flow with a timely push into high-voltage grid infrastructure via the DMC Power deal. Fundamentals and technicals favor a measured long entry; valuation is rich but supported by high returns and free cash flow. Trade plan included with clear entry, stop and target for a long-term (180 trading days) s…
Micron sits at the intersection of a structural AI demand boom and acute memory supply tightness. With HBM capacity sold out, gross margins expanding, a market cap near $485B and improving fundamentals, MU looks like a buyable long for investors who want exposure to AI infrastructure without buying GPUs. This trade idea lays out an entry at $431.22…
Materialise (MTLS) looks set for a rebound supported by its recurring-software revenue and improving demand in medical additive manufacturing. At a market cap of ~$305M and current price near $5.16, the risk/reward for a mid-term swing is attractive: enter $5.20, stop $4.80, target $6.40 (primary) and $7.20 (secondary). Key catalysts include trade …
Nexans is positioned to benefit from secular demand in electrification and grid upgrades while management pursues profitability fixes and capital discipline. We like a tactical long with a clear stop and a multi-month target that prices in improved margins and backlog conversion.
